Color Cosmetic Patent Picks: related news

Halliburton Tries To Patent Form Of Patent Trolling

We see all sorts of ridiculous patent applications and patents, but my favorites tend to be the patents that have to do with patents themselves (such as the patent app on a method for filing a patent). However, the folks over at Patently-O have highlighted a fascinating patent application from an attorney at Halliburton, which appears to be an attempt to patent the process of patent trolling. The application covers, quite explicitly, having a company (we'll say Company A) that does not invent something, find a company (Company B) that did invent something, but chose to use trade secret protection, rather than patents. Then, the Company A files a patent covering Company B's technology, and then use the issued patent to get money out of Company B.

Halliburton Applies For Patent-Trolling Patent

An anonymous reader writes "Halliburton, the company many folks know as Dick Cheney's previous employer, has apparently taken an interest in methods of patent trolling. In fact, according to Techdirt, the company has applied for a patent on patent trolling. Specifically, it's applied for a patent on the process of finding a company that protected an invention via trade secret, figuring out what that secret is, patenting it ... and then suing the original company. Hopefully, the patent office rejects this patent, because I somehow doubt that Halliburton is trying to get the patent as a way to block others from patent trolling."

Patent Lawsuit Silly Season: TechCrunch Sued For Patent Infringement After Critical Blog Post

There are different levels of ridiculousness when it comes to patent lawsuits, with the lowest of the low being patent lawsuits based more on spite than on any legitimate claim. For a while, it seemed like Ray Niro's use of the infamous JPG patent, to sue a bunch companies he just didn't like, was perhaps alone in that category. But, it appears that we now have a new entrant. Apparently, some company (who we won't even name, since there's a good chance it's doing this just to get press attention) sued a more well-known competitor for patent infringement, over a location-based services patent. Looking over the patent itself it's difficult to see how it was approved. People were talking about location-based profile matching a decade ago, let alone five years ago when this patent was filed.

Code Line Makes Color Splash with iPhone App

Color Expert contains powerful tools to help artists and designers identify, translate, capture and showcase color using their iPhone or iPod touch. Color Expert features an intuitive, interactive color wheel to identify a target color, and then finds several palettes backed by color theory. Designers, artists, decorators, and anyone who works with color will find this program indispensable. Color Expert is now available for purchase from the iTunes App Store.

Microsoft Employee Admits That Patent Disclosure Is A Myth

Defenders of the patent system quite frequently point out that one of the main benefits (some claim the only benefit) of the patent system is "disclosure." That is, because the patent system requires you to disclose your patent, the patent system is quite helpful in spreading ideas. This is a myth that's easily debunked on a few points. First, it only really makes sense to get patent protection if you know the idea will get disclosed or figured out anyway. In those cases, the disclosure via the patent system is meaningless, since the info would have gotten out anyway. Second, these days, thanks to "willful infringement" tripling the damages you pay, many corporations tell employees not to look at relevant patents, as it only opens up more liability.

SpreadsheetGear(R) Adds Microsoft Excel 2007 Open XML and Excel Compatible Charting Support to ASP.NET and Windows Forms Spreadsheet Component

Global CSS Styles */ .fc * { padding:0px; border:0px; margin:0px; color: inherit; background-color: inherit; } .fc, .fc TABLE, .fc TD, .fc INPUT, .fc SELECT { font-family:Helvetica; font-size:10px; text-align:left; } .fc IMG { display:block; } .fc TD {empty-cells: show;} /* END Global CSS */ .fc .data {color:#000000;text-align: left;} .fc A { text-decoration: none; color: #005FA4; } .fc A:hover{ text-decoration: underline; } .fc A.active{ text-decoration:underline; } .fc .row1 A, .fc .row2 A { text-decoration: none; color: #000000; font: normal 10px Verdana; } .fc .row TD{ } .fc .row1 TD, .fc .row2 TD {border-bottom:1px solid #808080; background-color:#FFFFFF; padding: 4px} .fc .row2 TD {background-color:#C0CDD7;} .fc .rowheader {background-color: #FFFFFF} .

Patent licensing after the Quanta decision

Patent owners have turned their attention to the terms and conditions of patent licenses now that the Supreme Court has recently expanded the scope of patent exhaustion through its Quanta Computer v. LG Electronics decision. "Patent exhaustion" is a term of art that generally means a patent owner can profit from the sale of a product covered by the patent only until the first sale of the product.

Arkados Awarded Patent on Universal Network Adapter Technology

announced today that it has been awarded a United States patent entitled "Integrated Universal Network Adapter." The U.S. Patent & Trademark Office awarded patent 7,440,443 to Arkados on August 2, 2008. The patent describes the concept of making physical network connections transparent to the user, by incorporating MAC/PHY technology that can adapt to different physical media into a single chip. In turn, this chip can be used to create products that can bridge between different physical media connections. The patent also describes a technique to dynamically choose the best medium to use based on data about the medium and the QoS requirements. The patent describes a common Medium Access Controller (MAC) and Physical Layer (PHY) communications interface that has an adapter allowing simultaneous communication over multiple media, such as pow

Benitec gets 'Control of Gene Expression' patent in New Zealand

Benitec Limited announced that a key patent 'Control of Gene Expression' part of the Graham patent family of RNA interference (RNAi) patents was granted in New Zealand. The "Control of Gene Expression patent" is a patent in the foundational Graham RNAi patent family and is related to the '099 patent currently under re-examination at the USPTO.

Ameranth Receives Major Patent for Its 'Casino Poker and Dealer Management System'

SAN DIEGO, Oct. 15 /PRNewswire/ -- Ameranth, Inc. announced today that it has received an official patent grant (#7,431,650) from the United States Patent and Trademark Office for a major patent, which will have a term extending to December 2025, on its revolutionary, automated poker and dealer system invention. The patent is the result of work dating from 2001. The award of this key strategic patent confirms Ameranth's leading and pioneering role in automating the modern poker room and clearly establishes Ameranth as a technology leader in virtually all automated aspects of poker rooms as part of Ameranth's overall 21st Century Casino(TM) vision. This new patent, combined with Ameranth's portfolio of wireless/web data synchronization patents (applicable to wireless gaming and many other casino applications) and Ameranth's recent and plan

Code Line intros iPhone color identification app

Code Line has released a new iPhone/iPod touch application, designed for critical color work. Color Expert provides users with tools that help identify and capture colors. Users take a picture containing a desired color, tap on the color specifically, and are then provided with a series of pallets based on it. Color Expert also features tools that allow users to fine-tune their choices, such as a color wheel.

Court Stays Patent Infringement Suit Brought against Candela byPalomar

Candela Corporation (NASDAQ: CLZR) announced today that the United States District Court for the District of Massachusetts agreed to stay the patent litigation that Palomar Medical Technologies, Inc. (�Palomar�) brought against the Company in August 2006. In that suit, Palomar asserts that the Company infringed upon U.S. Patent No. 5,735,844 (the ‘ “844 Patent�) and U.S. Patent No. 5,595,568, which is related to the ‘844 Patent (the ‘ “568 Patent�).

Court Stays Patent Infringement Suit Brought against Candela by Palomar

Candela Corporation (NASDAQ: CLZR) announced today that the United States District Court for the District of Massachusetts agreed to stay the patent litigation that Palomar Medical Technologies, Inc. (�Palomar�) brought against the Company in August 2006. In that suit, Palomar asserts that the Company infringed upon U.S. Patent No. 5,735,844 (the ‘ “844 Patent�) and U.S. Patent No. 5,595,568, which is related to the ‘844 Patent (the ‘ “568 Patent�).

Benitec Limited (ASX:BLT) Graham Gene Silencing Patent Granted in New Zealand

MELBOURNE, Australia, Oct 17, 2008 - Benitec Limited (ASX:BLT)(PINK:BNIKF) today announced that a key patent "Control of Gene Expression" part of the Graham patent family of RNA interference (RNAi) patents was granted in New Zealand. The "Control of Gene Expression patent" is a patent in the foundational Graham RNAi patent family and is related to the '099 patent currently under reexamination at the USPTO.

BASF Coatings uses artificial intelligence for color matching

BASF Automotive Refinish Solutions has developed a software program that applies artificial intelligence using neural networks to the process of color matching paint. Developed by BASF's Craig McClanahan, manager of color research for BASF Coatings North America, this artificial intelligence was designed to improve the efficiency and accuracy of the color matching process. This software uses a machine-learning algorithm to achieve its color matching ability from previously developed color formulations. Standard color matching, on the other hand, relies on human trial and error.

Color Cosmetic Patent Picks

C&T magazine's technical editor, Bud Brewster, features patents that have recently been approved for color cosmetics and makeup...

Key Fondaparinux Patent Allowed by U.S. Patent Office

Australian drug developer Alchemia Limited (ASX:ACL) today announced it had received a 'notice of allowance' for the United States patent application titled Synthetic Heparin Pentasaccharides (number 10/488,677). A notice of allowance is a notification to the patent applicant that they are entitled to a patent under the law and is issued for applications that have been filed based on "intent to use." The patent number will be assigned on payment of the grant fees.

Key Fondaparinux Patent Allowed by U.S. Patent Office

2008 NOV 7 - (NewsRx.com) -- Australian drug developer Alchemia Limited (ASX:ACL) announced it had received a 'notice of allowance' for the United States patent application titled Synthetic Heparin Pentasaccharides (number 10/488,677). A notice of allowance is a notification to the patent applicant that they are entitled to a patent under the law and is issued for applications that have been filed based on "intent to use." The patent number will be assigned on payment of the grant fees (see also Alchemia Limited).

Key Fondaparinux Patent Allowed by U.S. Patent Office

BRISBANE, Australia--(BUSINESS WIRE)--Oct 21, 2008 - Australian drug developer Alchemia Limited (ASX:ACL) today announced it had received a 'notice of allowance' for the United States patent application titled Synthetic Heparin Pentasaccharides (number 10/488,677). A notice of allowance is a notification to the patent applicant that they are entitled to a patent under the law and is issued for applications that have been filed based on "intent to use." The patent number will be assigned on payment of the grant fees.

DP7029 On the price elasticity of demand for patents

This paper investigates whether patent fee policies are a potential factor underlying the boom in patent applications observed in major patent offices. We provide the first panel-based evidence suggesting that fees affect the demand for patents in three major patent offices (EPO, USPTO and JPO), with a price elasticity of about -0.4 (similar to that of the residential demand for oil or water). The laxity of fee policies adopted by patent offices over the past 25 years therefore contributed, to a significant extent, to the rising propensity to patent observed since the mid-nineties. This is especially true at the European Patent Office, which has dramatically decreased its fees since the mid-1990s.

Ex parte Reexamination and Nanotechnology.

We should not take for granted that just because a patent has issued it is valid. Patent validity may be resolved in a reexamination process and anyone can request it. When a patent owner becomes aware of a problematic reference that may have an impact on the validity of a patent, he or she can bring that prior art and propose amendments to get around the prior art to the attention of the U.S. Patent and Trademark Office (PTO) to get a second review of the patent and hopefully a second stamp of approval. It is more difficult to break a patent in court if the PTO has already examined the prior art. The major advantage in choosing to seek a reexamination over litigation is that the reexamination costs in terms of time and money are much lower.

Patent challenge is finally resolved after 28 years

In 1980 Fritz Amstrup filed a Danish patent application with a patent claim directed to a method of degreasing beef intestines by using a centrifuge. Amstrup fitted a timer to the centrifuge to allow control of the treatment time. According to Amstrup, keeping to a very precise treatment time provided a careful degreasing of the outside of the intestines, while preserving the internal mucous membrane. This was important for the saleability of the product in Japan where beef intestines are considered a delicacy. Amstrup’s patent attorney did not conduct a novelty search prior to the filing and the application contained no concrete substantiation of the alleged effect on the intestines. The Danish Patent and Trademark Office (DKPTO) novelty search revealed an earlier German patent for an identical centrifuge, which described the cleaning

Search took 0.23 seconds.